Why is diagnosis tricky when addiction and ADHD overlap?Â
Diagnosing ADHD when addiction is also present is one of the most challenging tasks in mental health care. According to NICE and NHS England, substance use can both mask and mimic ADHD symptoms, creating confusion for clinicians and delaying accurate diagnosis.
How addiction hides ADHD symptoms
Intoxication with alcohol, stimulants, cannabis, or opioids can cause impulsivity, poor attention, and mood swings, traits that look almost identical to ADHD. During withdrawal, irritability, low mood, and inattention may also resemble ADHD, while fatigue or loss of motivation can hide underlying symptoms. Experts from the Royal College of Psychiatrists (RCPsych) note that these overlaps often lead to misinterpretation unless the full developmental history is considered.
Co-existing mental health issues, such as anxiety, depression, or trauma, are common in both ADHD and substance use disorders (SUDs). This makes it even harder to identify which symptoms are due to ADHD and which are secondary to addiction or emotional distress.
Systemic barriers in diagnosis
The problem is not just clinical; it is structural. Many addiction and ADHD services in the UK still operate in silos. Separate referral routes and limited training mean that professionals in addiction care may not recognise ADHD, while ADHD specialists may overlook substance use patterns (NHS England Taskforce, 2025). Stigma adds another layer: both conditions carry misconceptions that discourage people from seeking help or disclosing symptoms. This can delay diagnosis for years and increase relapse risk.
The impact on care pathways
A 2025 NHS England Taskforce report found that adults with ADHD and addiction face some of the longest waits for assessment, with many falling through gaps in care. NICE guidance emphasises that ADHD assessments should ideally occur after substance stabilisation, with information gathered from family, carers, or records to confirm symptoms of predate substance use (NICE NG87, 2025 update).
RCPsych’s College Report CR235 recommends structured interviews and longitudinal history to differentiate lifelong ADHD traits from temporary substance effects. NHS policy now encourages integrated, multidisciplinary teams to conduct dual assessments, improving accuracy and patient experience.
Moving forward
Integrated models are gaining traction across the UK, combining addiction, psychiatry, and neurodevelopmental expertise. Early data show these shared-care approaches to reduce diagnostic delays and misdiagnoses. Private and NHS-linked providers such as ADHD Certify also support comprehensive ADHD assessments that take account of coexisting addiction, aligning with NICE standards.
Takeaway
ADHD and addiction often blur into one another, but diagnosis becomes clearer when clinicians look at lifelong patterns, gather collateral history, and work across specialties. Integrated care, not isolated services, is key to ensuring people receive timely, accurate diagnosis and treatment.

